# Hemodynamic Monitoring: Invasive and Non-Invasive

## Introduction and Physiological Foundations

### Determinants of Cardiac Output

Cardiac output represents the fundamental measure of the heart's ability to meet the metabolic demands of the body and is defined as the product of heart rate and stroke volume. Stroke volume itself is governed by three interdependent variables: preload, afterload, and contractility. Understanding these determinants is essential for the intensivist, as therapeutic interventions in the critically ill patient are directed at optimizing one or more of these components to restore adequate tissue oxygen delivery.

The Frank-Starling relationship describes the intrinsic ability of the heart to increase its force of contraction in response to increased venous return and myocardial fiber stretch. Clinically, this relationship is depicted as a curve with an ascending limb, where increasing preload produces proportional increases in stroke volume, and a plateau phase, where further volume loading yields minimal hemodynamic benefit and may instead produce harm through venous congestion and pulmonary edema. The critical clinical distinction between a patient on the ascending limb (who will benefit from volume expansion) and one on the plateau (who will not) is the cornerstone of fluid responsiveness assessment and drives much of modern hemodynamic monitoring strategy.

Ventricular-arterial coupling, expressed as the ratio of effective arterial elastance (Ea) to end-systolic ventricular elastance (Ees), describes the efficiency of energy transfer from the left ventricle to the arterial system. An optimal Ea/Ees ratio of approximately 0.7 to 1.0 indicates maximal cardiovascular efficiency. Derangements in this coupling, as seen in septic shock (reduced Ees with low Ea) or acute heart failure (reduced Ees with elevated Ea), result in inefficient energy transfer and diminished cardiac performance. Recognizing and correcting ventricular-arterial uncoupling through vasopressor, inotrope, or vasodilator therapy represents an advanced hemodynamic optimization strategy.

Oxygen delivery (DO2) is the product of cardiac output and arterial oxygen content (CaO2), where CaO2 is determined by hemoglobin concentration, oxygen saturation, and the small contribution of dissolved oxygen. Under normal physiological conditions, oxygen consumption (VO2) remains independent of delivery because DO2 far exceeds metabolic demand. However, when DO2 falls below a critical threshold of approximately 330 mL/min/m2, VO2 becomes supply-dependent, and anaerobic metabolism ensues with resultant lactate accumulation. This critical DO2 concept underpins the urgency of hemodynamic resuscitation in shock states.

### Pressure vs. Flow Monitoring

The historical paradigm of hemodynamic monitoring in critical care relied heavily on static pressure-based parameters such as central venous pressure (CVP) and pulmonary artery occlusion pressure (PAOP) as surrogates for preload and guides for fluid administration. However, a large body of evidence, culminating in the meta-analysis by Marik and colleagues, has demonstrated that CVP performs no better than chance at predicting fluid responsiveness, with an area under the receiver operating characteristic curve of only 0.56. This poor predictive value stems from the fact that CVP is influenced by multiple factors beyond intravascular volume, including ventricular compliance, intrathoracic pressure, right ventricular function, and valvular disease.

In contrast, dynamic flow-based parameters such as stroke volume variation (SVV) and pulse pressure variation (PPV) exploit the cyclical changes in intrathoracic pressure during mechanical ventilation to assess the position of the heart on the Frank-Starling curve. These parameters have demonstrated consistently superior predictive performance, with areas under the curve exceeding 0.90 in patients receiving controlled mechanical ventilation with adequate tidal volumes and sinus rhythm. This paradigm shift from pressure-based to functional hemodynamic monitoring has fundamentally transformed how clinicians assess volume status and guide fluid therapy in the intensive care unit.

## Invasive Arterial Monitoring

### Arterial Catheterization

Arterial catheterization provides continuous, real-time blood pressure monitoring and facilitates frequent arterial blood gas sampling, both of which are indispensable in the management of hemodynamically unstable patients. The radial artery is the most commonly used site owing to its superficial location, the presence of dual blood supply to the hand via the ulnar artery and palmar arches, and the relatively low complication rate. Alternative sites include the femoral artery, which offers a larger vessel and may provide more accurate central aortic pressure measurement, as well as the dorsalis pedis, brachial, and axillary arteries.

The modified Allen test, historically used to assess adequacy of collateral ulnar circulation before radial artery cannulation, has been shown to have a sensitivity of only 54% with a specificity of 91%, providing limited clinical utility. Current evidence does not support the routine use of the modified Allen test as a prerequisite for radial artery catheterization, and most contemporary guidelines have abandoned its mandatory performance.

Complications of arterial catheterization include local thrombosis, which occurs in up to 19.7% of radial artery insertions when assessed by ultrasound, though clinically significant ischemia occurs in fewer than 1% of cases. Other complications include pseudoaneurysm formation, catheter-related infection (with rates of 0.7-0.8%), hematoma, and distal embolization. Proper zeroing and leveling of the transducer to the phlebostatic axis, defined as the intersection of the fourth intercostal space and the mid-axillary line, is essential for accurate pressure measurement and must be verified at the beginning of each nursing shift and whenever the patient's position changes.

### Arterial Waveform Analysis

The arterial pressure waveform provides a wealth of hemodynamic information beyond the simple numerical values of systolic and diastolic blood pressure. The normal waveform consists of a rapid systolic upstroke reflecting left ventricular ejection, a peak systolic pressure, the dicrotic notch representing aortic valve closure and the transition from systole to diastole, and the diastolic runoff phase during which blood flows peripherally through the arterial system.

Underdamping of the arterial line system occurs when the natural frequency of the catheter-tubing-transducer system falls below approximately 7 Hz, resulting in systolic overshoot and artifactual widening of the pulse pressure. This produces falsely elevated systolic and falsely low diastolic readings. Conversely, overdamping results from air bubbles, blood clots, kinks, or excessively compliant tubing, producing a diminished systolic peak, loss of the dicrotic notch, and an artificially narrow pulse pressure. The fast-flush (square wave) test is the bedside method for assessing the dynamic response of the system: a properly damped system will show a single overshoot followed by a rapid return to baseline, whereas an underdamped system shows multiple oscillations and an overdamped system shows a sluggish return without overshoot.

Arterial line transducer drift, in which the zero reference point gradually shifts over time, can introduce clinically significant measurement errors during prolonged ICU stays. Regular recalibration and comparison with non-invasive measurements help mitigate this source of error.

<image>Detailed annotated arterial waveform diagram showing normal morphology with labeled systolic upstroke, peak systolic pressure, dicrotic notch, diastolic pressure, and pulse pressure. Adjacent panels showing underdamped waveform with exaggerated oscillations and overdamped waveform with blunted peak and absent dicrotic notch. Include fast-flush square wave test results for each condition with catheter-tubing natural frequency annotations.</image>

### Pulse Pressure Variation (PPV) and Stroke Volume Variation (SVV)

Pulse pressure variation is a dynamic parameter that quantifies the respiratory-induced changes in arterial pulse pressure during positive-pressure mechanical ventilation. It is calculated as the difference between the maximum and minimum pulse pressures during a single respiratory cycle, divided by their average, and expressed as a percentage. A PPV threshold exceeding 13% predicts fluid responsiveness with a sensitivity of 88% and specificity of 89%, making it one of the most reliable bedside indicators of preload reserve.

However, the validity of PPV and SVV as predictors of fluid responsiveness depends on several strict prerequisites that must be met before these parameters can be interpreted with confidence. The patient must be receiving controlled mechanical ventilation without spontaneous respiratory efforts, the tidal volume must be at least 8 mL/kg of ideal body weight, the cardiac rhythm must be sinus (atrial fibrillation invalidates the measurement), the chest must be closed, and there must be no significant right ventricular failure (which causes respiratory variation through a different mechanism than preload dependence).

| Test | Threshold | Sensitivity | Specificity | Prerequisites / Limitations |
|---|---|---|---|---|
| Pulse Pressure Variation (PPV) | >13% | 88% | 89% | Controlled MV, Vt ≥8 mL/kg, sinus rhythm, closed chest |
| Stroke Volume Variation (SVV) | >12% | 82% | 86% | Same as PPV |
| Passive Leg Raise (PLR) | CO increase ≥10% | 85% | 91% | Universally applicable; must measure CO, not just BP |
| End-Expiratory Occlusion | CO or PP increase ≥5% | 87% | 100% | Controlled MV; invalid with spontaneous breathing |
| Mini-Fluid Challenge (100 mL) | VTI increase ≥10% | 95% | 78% | Requires real-time CO/VTI measurement |
| Tidal Volume Challenge | ΔPPV ≥3.5% absolute | 94% | 95% | Low Vt ventilation; transiently increase Vt from 6→8 mL/kg |
| IVC Distensibility Index | >18% | 90% | 90% | Mechanically ventilated patients only |

A recognized gray zone exists when PPV values fall between 9% and 13%, where the test is indeterminate and additional assessment methods are required to determine fluid responsiveness. The tidal volume challenge offers a practical solution to this problem: by transiently increasing the tidal volume from 6 to 8 mL/kg for one minute, clinicians can amplify the respiratory-induced hemodynamic variation. A change in PPV exceeding 3.5% absolute points during this maneuver reliably predicts volume responsiveness, even in patients ventilated with low tidal volumes for lung protection.

## Pulmonary Artery Catheter (PAC)

### Indications and Contraindication

The pulmonary artery catheter remains an important tool for the direct measurement of intracardiac pressures and cardiac output in situations where non-invasive assessment is insufficient to guide clinical decision-making. Primary indications include differentiation of shock etiology when bedside echocardiography and non-invasive hemodynamic assessment are inconclusive, management of severe pulmonary hypertension with right ventricular failure, and perioperative monitoring during cardiac surgery and liver transplantation where precise hemodynamic data are essential for optimal management.

Absolute contraindications to PAC insertion include the presence of a mechanical tricuspid or pulmonic valve prosthesis, through which the catheter cannot be safely advanced, and an implanted right ventricular assist device. Relative contraindications include the presence of an endocardial pacemaker, in which catheter manipulation risks lead displacement, and severe coagulopathy.

### Insertion and Waveform Interpretation

The PAC is typically inserted via the right internal jugular or subclavian vein through an introducer sheath. As the catheter is advanced, the balloon is inflated at approximately 15-20 cm from the insertion site, allowing the catheter to float through the right heart chambers with the flow of blood. The clinician monitors the sequential pressure waveforms on the bedside monitor to confirm appropriate catheter progression.

The right atrial waveform, encountered first, displays a mean pressure of 2-6 mmHg and exhibits the characteristic a wave (atrial contraction), c wave (tricuspid valve closure), x descent (atrial relaxation), v wave (passive atrial filling against a closed tricuspid valve), and y descent (passive atrial emptying after tricuspid opening). As the catheter crosses the tricuspid valve into the right ventricle, a dramatic increase in systolic pressure to approximately 25 mmHg with a low diastolic pressure of 0-5 mmHg is observed. Advancement into the pulmonary artery produces a maintained systolic pressure of approximately 25 mmHg but with a diastolic pressure rise to approximately 10 mmHg due to the dicrotic notch of the pulmonary valve. Finally, balloon inflation in a distal pulmonary artery produces the wedge (PAOP) tracing, with a mean pressure of 6-12 mmHg reflecting left atrial pressure.

Giant v waves in the wedge tracing warrant careful attention, as they suggest mitral regurgitation or ventricular septal defect. These must be distinguished from the pulmonary artery waveform by their timing relative to the ECG: v waves occur after the QRS complex, whereas PA systolic peaks coincide with the T wave.

### Derived Parameters

The PAC enables calculation of several derived hemodynamic parameters that are essential for characterizing the hemodynamic profile of shock states. Cardiac index, normally 2.5-4.0 L/min/m2, is measured by thermodilution using either intermittent bolus injection of cold saline or continuous thermal filament technology. Systemic vascular resistance, calculated as [(MAP - CVP) / CO] x 80 with a normal range of 800-1200 dyn.s/cm5, quantifies left ventricular afterload and helps differentiate distributive (low SVR) from cardiogenic (high SVR) shock. Pulmonary vascular resistance, calculated as [(mPAP - PAOP) / CO] x 80 with a normal range of 100-250 dyn.s/cm5, is critical for assessing pulmonary vascular disease and guiding therapy in right ventricular failure.

| Parameter | Formula | Normal Range | Clinical Significance |
|---|---|---|---|
| Cardiac Index (CI) | CO / BSA | 2.5–4.0 L/min/m² | Global cardiac pump function |
| Systemic Vascular Resistance (SVR) | [(MAP − CVP) / CO] × 80 | 800–1200 dyn·s/cm⁵ | LV afterload; low in distributive shock, high in cardiogenic shock |
| Pulmonary Vascular Resistance (PVR) | [(mPAP − PAOP) / CO] × 80 | 100–250 dyn·s/cm⁵ | RV afterload; elevated in pulmonary hypertension |
| Stroke Volume Index (SVI) | CI / HR | 33–47 mL/m²/beat | Per-beat cardiac performance |
| Mixed Venous O₂ Saturation (SvO₂) | Measured from PA distal port | 65–75% | Global O₂ supply-demand balance |
| Oxygen Delivery Index (DO₂I) | CI × CaO₂ × 10 | 500–600 mL/min/m² | Total oxygen delivered to tissues |
| Oxygen Consumption Index (VO₂I) | CI × (CaO₂ − CvO₂) × 10 | 110–160 mL/min/m² | Tissue metabolic demand |
| Oxygen Extraction Ratio (O₂ER) | VO₂ / DO₂ | 20–30% | Tissue extraction efficiency |

Mixed venous oxygen saturation (SvO2), measured from the distal port of the PAC in the pulmonary artery, normally ranges from 65-75% and reflects the global balance between oxygen supply and demand. A low SvO2 indicates either inadequate delivery (low cardiac output, anemia, hypoxemia) or excessive demand (fever, agitation, pain), while a high SvO2 may suggest impaired extraction (as in sepsis) or left-to-right shunting. Additional derived oxygen transport parameters include the DO2 index, VO2 index, and oxygen extraction ratio (O2ER), which normally ranges from 20-30%.

### Evidence and Controversy

Despite its extensive physiological rationale, the PAC has been the subject of considerable controversy regarding its impact on clinical outcomes. The PAC-Man trial of 2005, a large multicenter randomized controlled trial, demonstrated no difference in hospital mortality between patients managed with and without a PAC. Similarly, the ESCAPE trial of 2005, which examined PAC-guided therapy in advanced heart failure, found no benefit in terms of days alive and out of the hospital, while patients in the PAC group experienced more adverse events.

These trials, along with the increasing availability of non-invasive and minimally invasive cardiac output monitoring technologies, have led to a significant decline in PAC utilization over the past two decades. However, the PAC retains an important role in targeted clinical scenarios where the complexity of the hemodynamic picture exceeds the diagnostic capability of non-invasive tools, particularly in patients with severe pulmonary hypertension, right ventricular failure, or mixed shock physiology where precise measurement of intracardiac pressures guides therapeutic decisions.

<image>Cross-sectional illustration of a pulmonary artery catheter showing its four lumens (proximal port, distal port, thermistor, balloon), with an inset showing the catheter path through the right heart chambers. Below, a continuous waveform tracing showing the characteristic pressure waveforms encountered during flotation from right atrium through right ventricle to pulmonary artery and wedge position, with labeled chambers, normal pressure values, and distances from insertion site.</image>

## Non-Invasive and Minimally Invasive Cardiac Output Monitoring

### Pulse Contour Analysis

Pulse contour analysis systems estimate continuous cardiac output from the arterial pressure waveform using proprietary algorithms that relate the shape of the arterial waveform to stroke volume. These systems are broadly classified into calibrated and uncalibrated devices based on whether they require an independent cardiac output measurement for initial calibration.

Calibrated systems include the PiCCO (Pulse index Continuous Cardiac Output) platform, which uses transpulmonary thermodilution for calibration and requires both a central venous catheter and a femoral arterial line. Beyond cardiac output, PiCCO provides unique volumetric parameters including global end-diastolic volume (GEDV), extravascular lung water (EVLW), and pulmonary vascular permeability index (PVPI). EVLW values exceeding 10 mL/kg have been associated with increased mortality in ARDS and can guide fluid management by providing a quantitative assessment of pulmonary edema. The LiDCO system uses lithium dilution for calibration and applies pulse power analysis to the arterial waveform.

Uncalibrated systems, such as the FloTrac/Vigileo platform (now in its fourth generation) and the ClearSight/CNAP finger cuff technology, estimate cardiac output without the need for an independent calibration measurement. While this offers the advantage of simplicity, the accuracy of uncalibrated systems is limited in vasoplegic states and during rapid hemodynamic changes. The fourth-generation FloTrac algorithm has improved performance in low SVR states compared to earlier iterations, but clinicians should remain aware of its limitations in the most hemodynamically deranged patients.

### Echocardiography-Based Assessment

Echocardiography has emerged as an indispensable tool for hemodynamic assessment in critical care, offering both structural and functional information in a non-invasive, repeatable format. Cardiac output can be calculated by measuring the velocity-time integral (VTI) at the left ventricular outflow tract (LVOT) using pulsed-wave Doppler and multiplying by the LVOT cross-sectional area, which is derived from the LVOT diameter measured in the parasternal long-axis view. The resulting stroke volume, when multiplied by heart rate, provides a reliable estimate of cardiac output.

The VTI is also valuable as a dynamic measure of fluid responsiveness. Changes in VTI greater than 12-15% in response to a passive leg raise or fluid challenge reliably predict volume responsiveness. The inferior vena cava (IVC) assessment offers another echocardiographic window into volume status: a distensibility index exceeding 18% in mechanically ventilated patients suggests fluid responsiveness, while IVC collapsibility greater than 50% in spontaneously breathing patients has been used as a volume assessment tool, though its reliability is significantly lower due to the variability of respiratory effort and the high false-positive rate.

### Bioreactance and Bioimpedance

The NICOM system by Cheetah Medical represents the bioreactance approach to non-invasive cardiac output monitoring, measuring the phase shift of an oscillating electrical current applied across the thorax. This phase shift correlates with aortic blood flow and can be used to derive stroke volume and cardiac output continuously without any invasive instrumentation. While the technology offers moderate correlation with thermodilution (r = 0.58-0.82 across studies), its accuracy is limited in shock states, particularly when significant peripheral edema or pleural effusions alter thoracic bioimpedance.

### Esophageal Doppler

The CardioQ esophageal Doppler monitor measures blood flow velocity in the descending thoracic aorta using a small Doppler probe positioned in the esophagus. The corrected flow time (FTc), derived from the Doppler waveform and adjusted for heart rate, provides a preload assessment: an FTc less than 330 ms suggests hypovolemia. Intraoperative goal-directed therapy studies using esophageal Doppler, beginning with the landmark work of Mythen and Webb in 1995, demonstrated reduced hospital length of stay when fluid management was guided by this technology. However, esophageal Doppler requires a cooperative or sedated patient and does not measure total cardiac output, as it samples only descending aortic flow.

## Functional Hemodynamic Assessment

### Passive Leg Raise (PLR)

The passive leg raise maneuver has emerged as the gold standard bedside test for fluid responsiveness and is applicable across virtually all patient populations, including those with spontaneous breathing, arrhythmias, low tidal volume ventilation, and open chest conditions that invalidate PPV and SVV. The technique involves transitioning the patient from a semi-recumbent position (with the trunk elevated at 45 degrees) to a position where the trunk is flat and the legs are elevated to 45 degrees, effectively autotransfusing approximately 300 mL of blood from the lower extremities and splanchnic circulation into the central compartment.

The critical methodological point is that the response to PLR must be assessed by measuring changes in cardiac output (using echocardiographic VTI, pulse contour analysis, or esophageal Doppler) rather than relying on blood pressure changes alone, which are insensitive to the hemodynamic effects of PLR. An increase in cardiac output of 10% or more within 30 to 90 seconds of leg elevation predicts fluid responsiveness with a sensitivity of 85% and specificity of 91%. The transient and fully reversible nature of PLR makes it especially valuable in patients where the risk-benefit ratio of an empiric fluid bolus is uncertain.

### End-Expiratory Occlusion Test

The end-expiratory occlusion test exploits the physiology of mechanical ventilation by performing a 15-second end-expiratory hold, which transiently eliminates the cyclic impediment to venous return caused by positive-pressure inspiration. This brief cessation of positive pressure allows a transient increase in venous return and, in fluid-responsive patients, a detectable increase in cardiac output or pulse pressure of 5% or more. The simplicity of this maneuver, requiring only a ventilator with an end-expiratory hold function, makes it an attractive adjunct to other fluid responsiveness assessments. However, the test is not valid in patients with spontaneous breathing efforts, as the irregular respiratory pattern prevents standardized interpretation.

### Mini-Fluid Challenge

The mini-fluid challenge involves the rapid infusion of a small volume of crystalloid, typically 100 mL over one minute, followed by immediate assessment of changes in stroke volume or VTI. An increase in VTI of 10% or more following this small volume infusion predicts a positive response to a full 500 mL fluid bolus. This approach minimizes the risk of fluid overload in patients whose volume status is uncertain and for whom a larger empiric bolus might cause harm, particularly in those with borderline cardiac function or established ARDS.

<image>Clinical algorithm flowchart for assessing fluid responsiveness in the ICU. Starting node: "Is the patient in shock and potentially fluid responsive?" Decision branches based on ventilation mode (mechanical vs. spontaneous), rhythm (sinus vs. arrhythmia), and tidal volume (>=8 vs. <8 mL/kg). Each path leads to appropriate test: PPV/SVV for regular rhythm on controlled ventilation with adequate Vt, passive leg raise for all others, end-expiratory occlusion test as alternative, with thresholds and response criteria at each endpoint. Color-coded green for fluid responsive, red for non-responsive pathways.</image>

## Tissue Perfusion and Microcirculation Monitoring

### Lactate

Serum lactate has become one of the most widely used biomarkers of tissue perfusion in critical care. While a single elevated lactate value provides diagnostic information, the true clinical power of lactate lies in serial measurement and the assessment of lactate clearance over time. A lactate clearance of greater than 20% at two hours following initiation of resuscitation has been consistently associated with improved outcomes across multiple studies and has been incorporated into the Surviving Sepsis Campaign guidelines as a resuscitation target.

The ANDROMEDA-SHOCK trial of 2019 provided an important evolution in perfusion-guided resuscitation by comparing a strategy targeting peripheral perfusion status (specifically capillary refill time with a target of less than 3 seconds) against a lactate-guided strategy. The trial demonstrated that peripheral perfusion-guided resuscitation was non-inferior to lactate-guided resuscitation for 28-day mortality, with a trend toward less 72-hour organ dysfunction in the perfusion-guided group. This finding has reinvigorated interest in clinical examination as a resuscitation endpoint and validated capillary refill time as a simple, reproducible, and physiologically meaningful measure of tissue perfusion.

### Venous-Arterial CO2 Gap

The venous-arterial CO2 gap, calculated as the difference between mixed venous (or central venous) PCO2 and arterial PCO2, provides complementary information about the adequacy of cardiac output that is not captured by oxygen-based parameters alone. Under normal conditions, this gap is less than 6 mmHg. An elevated P(v-a)CO2 gap in the setting of a normal or elevated ScvO2 represents a clinically important scenario: it suggests that while global oxygen delivery may appear adequate (as reflected by the normal ScvO2), cardiac output is actually insufficient to clear CO2 produced at the tissue level. This pattern of hemodynamic incoherence should prompt reassessment of cardiac output adequacy and consideration of inotropic support or further volume optimization.

### Central Venous Oxygen Saturation (ScvO2)

Central venous oxygen saturation is measured from the superior vena cava via a central venous catheter and serves as a practical surrogate for true mixed venous oxygen saturation, typically running approximately 5% higher than SvO2. The landmark Early Goal-Directed Therapy trial by Rivers and colleagues established a target ScvO2 of 70% or greater as a resuscitation endpoint in severe sepsis. However, subsequent large multicenter trials, including ProCESS, ARISE, and ProMISe, demonstrated no benefit of protocolized ScvO2-guided care over usual care, likely reflecting improvements in standard sepsis management that rendered the protocol redundant.

Despite these negative trials, ScvO2 retains clinical utility as a trend indicator and for identifying patients at the extremes of the oxygen supply-demand spectrum. An ScvO2 below 60% should prompt urgent investigation into the cause of inadequate oxygen delivery, while a persistently elevated ScvO2 above 80% in a patient with clinical signs of shock may indicate impaired oxygen extraction at the tissue level, a hallmark of microcirculatory dysfunction in sepsis.

### Sublingual Microcirculation

The recognition that macrocirculatory normalization (adequate blood pressure, cardiac output, and lactate clearance) does not guarantee restoration of microcirculatory flow has driven the development of direct microcirculation imaging techniques. Incident dark field (IDF) imaging of the sublingual microcirculation allows real-time visualization of capillary flow patterns and assessment of parameters including microvascular flow index (MFI), proportion of perfused vessels (PPV), and perfused vessel density (PVD).

Research using these technologies has revealed the phenomenon of hemodynamic incoherence, in which persistent microcirculatory dysfunction coexists with apparently normalized macrocirculatory parameters. This dissociation between macro- and microcirculatory function may explain the ongoing organ dysfunction and adverse outcomes observed in some patients despite apparently successful macrocirculatory resuscitation. While currently limited to the research domain, sublingual microcirculation assessment represents a frontier in hemodynamic monitoring that may eventually guide individualized resuscitation strategies.

## Key Clinical Pearls

- CVP should not be used to guide fluid resuscitation; a single CVP value cannot predict fluid responsiveness
- Dynamic parameters (PPV, SVV) require specific conditions: mechanical ventilation, adequate Vt, sinus rhythm, closed chest
- Passive leg raise is the most universally applicable test for fluid responsiveness -- measure CO change, not just BP
- EVLW by PiCCO provides quantitative assessment of pulmonary edema and can guide fluid management in ARDS
- An elevated P(v-a)CO2 gap with normal ScvO2 should prompt reassessment of cardiac output adequacy
- Integrate multiple monitoring modalities -- no single parameter provides a complete hemodynamic picture
- Always correlate monitoring data with clinical assessment: capillary refill, mottling, urine output, mental status

## References

1. Teboul JL, Monnet X, Chemla D, Michard F. Arterial pulse pressure variation with mechanical ventilation. Am J Respir Crit Care Med. 2019;199(1):22-31.
2. Monnet X, Marik PE, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med. 2016;42(12):1935-1947.
3. Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man). Lancet. 2005;366(9484):472-477.
4. Hernandez G, Ospina-Tascon GA, Damiani LP, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654-664.
5. Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41(7):1774-1781.